Company Wntresearch AB Nasdaq Stockholm
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- SEK | - |
03/05 | WntResearch AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
29/02 | WntResearch AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Per Norlén
CEO | Chief Executive Officer | 54 | 10/01 |
Founder | 68 | 24/07/24 | |
Anders Tidfors
DFI | Director of Finance/CFO | - | 11/20/11 |
Kicki Johansson
COO | Chief Operating Officer | 66 | 01/18/01 |
Chief Tech/Sci/R&D Officer | 62 | 01/16/01 | |
Corporate Officer/Principal | 56 | 01/19/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 09/15/09 | |
Founder | 68 | 24/07/24 | |
Chairman | 62 | 01/22/01 | |
Gudrun Anstrén
BRD | Director/Board Member | 69 | 15/18/15 |
Director/Board Member | - | - | |
Mats Lindskog
BRD | Director/Board Member | - | 01/23/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,660,590 | 1,309,629 ( 15.12 %) | 0 | 15.12 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+11.91% | 12TCr | |
+11.60% | 11TCr | |
-4.68% | 2.43TCr | |
-0.82% | 2.2TCr | |
-10.12% | 1.82TCr | |
-42.12% | 1.64TCr | |
-17.47% | 1.56TCr | |
+2.77% | 1.36TCr | |
+34.58% | 1.23TCr |
- Stock Market
- Equities
- WNT Stock
- Stock
- Company Wntresearch AB